Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Clin Imaging. 2020 Sep 19;69:269–279. doi: 10.1016/j.clinimag.2020.09.003

Fig. 5.

Fig. 5.

49-year-old with remote history of phyllodes tumor with new palpable left breast mass. MLO low-energy image (A) demonstrates an obscured mass underlying a triangular palpable skin marker. The full extent of the mass is not well delineated due to overlapping dense tissue. MLO recombined image (B) clearly shows a large avidly enhancing retroareolar mass. Targeted US image (C) demonstrates a solid vascular mass, which correlates to the CEM enhancement and palpable finding. US-guided biopsy yielded recurrent phyllodes tumor. CEM is beneficial in delineating the extent of suspicious abnormalities in areas of dense parenchymal breast tissue.